Cargando…
Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol
BACKGROUND: Mesenchymal stromal cells (MSCs) have significant immunomodulatory and tissue repair capabilities, mediated partly by conditioned media or through secreted extracellular vesicles (MSC-EVs). Infection with SARS-CoV-2 can cause mild to life-threatening illness due to activated immune respo...
Autores principales: | Kirkham, Aidan M., Monaghan, Madeline, Bailey, Adrian J. M., Shorr, Risa, Lalu, Manoj M., Fergusson, Dean A., Allan, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441251/ https://www.ncbi.nlm.nih.gov/pubmed/34526123 http://dx.doi.org/10.1186/s13643-021-01803-5 |
Ejemplares similares
-
Mesenchymal Stromal Cells As a Therapeutic Intervention for COVID-19: Second Iteration of a Living Systematic Review and Meta-Analysis
por: Kirkham, Aidan, et al.
Publicado: (2022) -
Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19
por: Kirkham, Aidan M., et al.
Publicado: (2022) -
Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval—FASTER Approval
por: Kirkham, Aidan M, et al.
Publicado: (2022) -
Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?
por: Kirkham, Aidan M., et al.
Publicado: (2023) -
Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: a preclinical systematic review protocol
por: Tieu, Alvin, et al.
Publicado: (2019)